Business Standard

Monday, December 23, 2024 | 08:08 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Nifty Pharma outshines benchmarks, up 2%; Cipla, Sun Pharma hit 52-wk highs

Shares of Glenmark Pharma, Granules India, Divi's Laboratories, Torrent Pharma, Lupin and Aurobindo Pharma, surged in the range of 2 per cent to 6 per cent in Monday's intra-day trade

pharma
Premium

SI Reporter Mumbai
Shares of pharmaceutical companies were in focus as frontline stocks rallied up to 6 per cent in Monday's intra-day trade, due to strong business outlook. At 12:12 PM, the Nifty Pharma, and the S&P BSE Healthcare indices were up  2 per cent each, as compared to 0.4 per cent decline in the Nifty50, and the S&P BSE Sensex.

Among individual stocks, shares of Lupin, and Aurobindo Pharma surged in the range of 5 per cent to 6 per cent. Glenmark Pharmaceuticals, Granules India, Divi’s Laboratories, Torrent Pharmaceuticals, on the other hand, were up in the range of 2 per

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in